Skip to content

SCHEDULE 13D/AAccepted Mar 3, 5:00 PM ET

Vir Biotechnology, Inc. SCHEDULE 13D/A

ARCH Venture Fund IX, L.P.

Accepted (ET)

5:00 PM

Mar 3, 2026

Filed

Mar 3, 2026

Documents

1

Size

19.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.